- Report
- August 2024
- 86 Pages
China
From €1602EUR$1,800USD£1,385GBP
- Report
- August 2024
- 76 Pages
China
From €1602EUR$1,800USD£1,385GBP
- Report
- August 2024
- 133 Pages
China
From €1602EUR$1,800USD£1,385GBP
- Report
- August 2024
- 50 Pages
China
From €1602EUR$1,800USD£1,385GBP
- Report
- August 2024
- 207 Pages
China
From €3559EUR$4,000USD£3,078GBP
- Report
- August 2024
- 238 Pages
China
From €3559EUR$4,000USD£3,078GBP
- Report
- August 2024
- 223 Pages
China
From €3559EUR$4,000USD£3,078GBP
- Report
- August 2024
- 229 Pages
China
From €3559EUR$4,000USD£3,078GBP
- Report
- August 2024
- 101 Pages
China
From €1602EUR$1,800USD£1,385GBP
- Report
- August 2024
- 104 Pages
China
From €1602EUR$1,800USD£1,385GBP
- Report
- August 2024
- 66 Pages
Thailand
From €1775EUR$1,995USD£1,535GBP
- Clinical Trials
- July 2024
- 745 Pages
Global
From €3070EUR$3,450USD£2,654GBP
- Report
- July 2024
- 116 Pages
Global
From €4004EUR$4,500USD£3,462GBP
- Report
- July 2024
- 296 Pages
Global
From €2180EUR$2,450USD£1,885GBP
- Report
- July 2024
- 268 Pages
China
From €3559EUR$4,000USD£3,078GBP
- Report
- July 2024
- 78 Pages
China
From €1602EUR$1,800USD£1,385GBP
- Report
- July 2024
- 141 Pages
China
From €1602EUR$1,800USD£1,385GBP
- Report
- July 2024
- 324 Pages
Europe
From €2080EUR$2,338USD£1,798GBP
€2447EUR$2,750USD£2,116GBP
- Report
- July 2024
- 19 Pages
Global
From €13343EUR$14,995USD£11,537GBP
- Report
- June 2024
- 112 Pages
Global
From €13343EUR$14,995USD£11,537GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more